Lan Ting-Yuan; Lin Yen-Chun; Tseng Tai-Chung; Yang Hung-Chih; Kao Jui-Hung; Cheng Chiao-Feng; Lee Tai-Ju; Huang Shang-Chin; Lu Cheng-Hsun; Li Ko-Jen; Hsieh Song-Chou
(거트앤리버 소화기연관학회협의회, 2023-03)
Background/Aims: Rituximab is known to be associated with high hepatitis B virus (HBV) reactivation rate in patients with resolved HBV infection and hematologic malignancy. However, data regarding HBV reactivation (HBVr) ...